Explore

Trendline Trendline
Precision BioSciences to Host Webcast on New Hepatitis B Treatment Data

Precision BioSciences to Host Webcast on New Hepatitis B Treatment Data

Precision BioSciences to Host Webcast on New Hepatitis B Treatment Data
Trendline Trendline
FDA to Review Moderna's mRNA Flu Vaccine After Initial Rejection

FDA to Review Moderna's mRNA Flu Vaccine After Initial Rejection

FDA to Review Moderna's mRNA Flu Vaccine After Initial Rejection
Trendline Trendline
Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma

Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma

Arsenal Medical Receives FDA Approval for NeoCast Trial in Chronic Subdural Hematoma
Trendline Trendline
Obsidian Therapeutics Reports Positive Phase 2 Results for OBX-115 in Melanoma

Obsidian Therapeutics Reports Positive Phase 2 Results for OBX-115 in Melanoma

Obsidian Therapeutics Reports Positive Phase 2 Results for OBX-115 in Melanoma
Trendline Trendline
Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026

Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026

Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026
Trendline Trendline
Precision BioSciences to Discuss New Data on Gene Editing Therapy for Hepatitis B at Upcoming Webcast

Precision BioSciences to Discuss New Data on Gene Editing Therapy for Hepatitis B at Upcoming Webcast

Precision BioSciences to Discuss New Data on Gene Editing Therapy for Hepatitis B at Upcoming Webcast
Trendline Trendline
Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes
Trendline Trendline
Eli Lilly's Experimental Weight-Loss Shot Retatrutide Shows Promising Results in Late-Stage Study

Eli Lilly's Experimental Weight-Loss Shot Retatrutide Shows Promising Results in Late-Stage Study

Eli Lilly's Experimental Weight-Loss Shot Retatrutide Shows Promising Results in Late-Stage Study
Trendline Trendline
Caliway Receives FDA Clearance for Phase 3 Study of Fat Reduction Drug CBL-514

Caliway Receives FDA Clearance for Phase 3 Study of Fat Reduction Drug CBL-514

Caliway Receives FDA Clearance for Phase 3 Study of Fat Reduction Drug CBL-514
Trendline Trendline
Eli Lilly's Retatrutide Shows Significant Weight Loss in Obesity Trial

Eli Lilly's Retatrutide Shows Significant Weight Loss in Obesity Trial

Eli Lilly's Retatrutide Shows Significant Weight Loss in Obesity Trial
Trendline Trendline
Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases
Trendline Trendline
Longeveron Outlines Strategic Repositioning and Key Milestones for 2026

Longeveron Outlines Strategic Repositioning and Key Milestones for 2026

Longeveron Outlines Strategic Repositioning and Key Milestones for 2026